Trophos Publishes The Identification And Characterization Of The Novel Cardioprotective Compound, TRO40303
Source: Medical News Today
Thursday 29th July, 2010
Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announc... ...
Read the full story at
Medical News Today
Email this story to a friend
Have your say on this story